Zoledronic Acid for prevention of bone and muscle loss after BAriatric Surgery (ZABAS)-a study protocol for a randomized controlled trial.

Gam S, Gram B, Juhl CB, Hermann AP, Hansen SG

Open source

DOI
10.1186/s13063-022-06766-z
Published
2022 Oct 8
Container
Trials
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13063-022-06766-z,
  title = {Zoledronic Acid for prevention of bone and muscle loss after BAriatric Surgery (ZABAS)-a study protocol for a randomized controlled trial.},
  author = {Gam S and Gram B and Juhl CB and Hermann AP and Hansen SG},
  year = {2022},
  journal = {Trials},
  doi = {10.1186/s13063-022-06766-z},
  url = {https://doi.org/10.1186/s13063-022-06766-z}
}

RIS

TY  - JOUR
TI  - Zoledronic Acid for prevention of bone and muscle loss after BAriatric Surgery (ZABAS)-a study protocol for a randomized controlled trial.
AU  - Gam S
AU  - Gram B
AU  - Juhl CB
AU  - Hermann AP
AU  - Hansen SG
PY  - 2022
JO  - Trials
DO  - 10.1186/s13063-022-06766-z
UR  - https://doi.org/10.1186/s13063-022-06766-z
ER  - 

APA

S, G., B, G., CB, J., AP, H., & SG, H. (2022). Zoledronic Acid for prevention of bone and muscle loss after BAriatric Surgery (ZABAS)-a study protocol for a randomized controlled trial.. Trials. https://doi.org/10.1186/s13063-022-06766-z

Source records